Elevated expression of Golgi Transport 1B promotes the progression of cervical cancer by activating the NF-kappaB signaling pathway via interaction with TANK-Binding Kinase 1
Carcinogenesis · 2025
DOI: 10.1093/carcin/bgae054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2025. Verfasst von Yixuan Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 20…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, NF-kappa B, Protein Serine-Threonine Kinases, Membrane Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Sailing Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
As a preventable disease, cervical cancer (cervical squamous cell carcinoma and endocervical adenocarcinoma—CESC) remains a tumor with high morbidity and mortality worldwide, underscoring the pressing need for effective treatment strategies. This research identified Golgi transport 1B (GOLT1B) as a critical gene involved in the development of cervical cancer. Gene Expression Omnibus (GEO) datasets were investigated to determine the upregulation of GOLT1B in cervical cancer tissue compared with normal tissue. Besides, GOLT1B was found to predict poor prognosis in cervical cancer by utilizing Gene Expression Profiling Interactive Analysis (GEPIA). The functional assay indicated that GOLT1B promoted CESC viability and migration in vitro and in vivo. RNA sequencing results suggested that GOLT1B likely influenced the nuclear factor-kappaB (NF-κB) pathway. The subsequent western blot and dual luciferase reporter assay revealed the interaction between GOLT1B and TANK binding kinase 1 (TBK1), modulating the NF-κB pathway. More importantly, GOLT1B was also found to regulate immune cell infiltration, suggesting its potential role in the tumor microenvironment. In conclusion, GOLT1B promotes CESC progression via interaction with TBK1 and augmentation of NF-κB signaling-mediated cancer-associated inflammation, which provides us with a new approach to CESC target therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 201306, P.R. China.
- Department of Biliary-Pancreatic Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, P.R. China.
- State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200240, P.R. China.
ORCID-Profile: Yincheng Teng, Yang Zhou
Förderung
- Science and Technology Commission of Shanghai Sailing Program
- National Natural Science Foundation of China
Zitieren
APA
Sun, Y., Peng, Q., Wang, R., Yin, Y., Mutailifu, M., Hu, L., Teng, Y., & Zhou, Y. (2025). Elevated expression of Golgi Transport 1B promotes the progression of cervical cancer by activating the NF-kappaB signaling pathway via interaction with TANK-Binding Kinase 1. Carcinogenesis. https://doi.org/10.1093/carcin/bgae054
Vancouver
Sun Y, Peng Q, Wang R, Yin Y, Mutailifu M, Hu L, et al. Elevated expression of Golgi Transport 1B promotes the progression of cervical cancer by activating the NF-kappaB signaling pathway via interaction with TANK-Binding Kinase 1. Carcinogenesis. 2025. doi:10.1093/carcin/bgae054
BibTeX
@article{Sun2025,
author = {Sun, Yixuan and Peng, Qihua and Wang, Ruiwen and Yin, Yifan and Mutailifu, Musitaba and Hu, Lipeng and Teng, Yincheng and Zhou, Yang},
title = {Elevated expression of Golgi Transport 1B promotes the progression of cervical cancer by activating the NF-kappaB signaling pathway via interaction with TANK-Binding Kinase 1},
journal = {Carcinogenesis},
year = {2025},
doi = {10.1093/carcin/bgae054}
}
EUVIMED